198 related articles for article (PubMed ID: 17762573)
21. Strategies for human papillomavirus therapeutic vaccines and other therapies based on the E6 and E7 oncogenes.
Govan VA
Ann N Y Acad Sci; 2005 Nov; 1056():328-43. PubMed ID: 16387699
[TBL] [Abstract][Full Text] [Related]
22. Education about human papillomavirus and human papillomavirus vaccines in adolescents.
Kollar LM; Kahn JA
Curr Opin Obstet Gynecol; 2008 Oct; 20(5):479-83. PubMed ID: 18797272
[TBL] [Abstract][Full Text] [Related]
23. Vaccines against cervical cancer.
Rogers LJ; Eva LJ; Luesley DM
Curr Opin Oncol; 2008 Sep; 20(5):570-4. PubMed ID: 19106663
[TBL] [Abstract][Full Text] [Related]
24. Update: human papillomavirus infection remains highly prevalent and persistent among HIV-infected individuals.
Kojic EM; Cu-Uvin S
Curr Opin Oncol; 2007 Sep; 19(5):464-9. PubMed ID: 17762572
[TBL] [Abstract][Full Text] [Related]
25. Prospects and prejudices of human papillomavirus vaccines in India.
Das BC; Hussain S; Nasare V; Bharadwaj M
Vaccine; 2008 May; 26(22):2669-79. PubMed ID: 18455843
[TBL] [Abstract][Full Text] [Related]
26. Strengthening prevention programs to eliminate cervical cancer in the Nordic countries.
Dillner L; Pagliusi S; Bray F; Lorincz A; Kjaer SK; Anttila A; Iversen OE; Dillner J; Lehtinen M; Paavonen J
Acta Obstet Gynecol Scand; 2008; 87(5):489-98. PubMed ID: 18446530
[TBL] [Abstract][Full Text] [Related]
27. [Value of general human papillomavirus vaccination in sexually active women].
Hampl M
Dtsch Med Wochenschr; 2009 Apr; 134 Suppl 2():S95-9. PubMed ID: 19353480
[TBL] [Abstract][Full Text] [Related]
28. Fostering acceptance of human papillomavirus vaccines.
Dekker AH
J Am Osteopath Assoc; 2006 Mar; 106(3 Suppl 1):S14-8. PubMed ID: 16729556
[TBL] [Abstract][Full Text] [Related]
29. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
Arbyn M; Benoy I; Simoens C; Bogers J; Beutels P; Depuydt C
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):321-30. PubMed ID: 19124515
[TBL] [Abstract][Full Text] [Related]
30. Short version of the German evidence-based Guidelines for prophylactic vaccination against HPV-associated neoplasia.
Pathirana D; Hillemanns P; Petry KU; Becker N; Brockmeyer NH; Erdmann R; Gissmann L; Grundhewer H; Ikenberg H; Kaufmann AM; Klusmann J; Kopp I; Pfister H; Rzany B; Schneede P; Schneider A; Smola S; Winter-Koch N; Wutzler P; Gross G
Vaccine; 2009 Jul; 27(34):4551-9. PubMed ID: 19524337
[TBL] [Abstract][Full Text] [Related]
31. Preventive and therapeutic HPV vaccines.
Monie A; Hung CF; Wu TC
Curr Opin Investig Drugs; 2007 Dec; 8(12):1038-50. PubMed ID: 18058574
[TBL] [Abstract][Full Text] [Related]
32. A meta-analysis of human papillomavirus type-distribution in women from South Asia: implications for vaccination.
Bhatla N; Lal N; Bao YP; Ng T; Qiao YL
Vaccine; 2008 Jun; 26(23):2811-7. PubMed ID: 18450340
[TBL] [Abstract][Full Text] [Related]
33. Recombinant vaccines for the prevention of human papillomavirus infection and cervical cancer.
Palmer KE; Jenson AB; Kouokam JC; Lasnik AB; Ghim SJ
Exp Mol Pathol; 2009 Jun; 86(3):224-33. PubMed ID: 19454268
[TBL] [Abstract][Full Text] [Related]
34. [Epidemiology of vulvar intra-epithelial neoplasias].
Akerman G; Dussour C; Haddad B; Paniel BJ; Rouzier R
Gynecol Obstet Fertil; 2007 Dec; 35(12):1251-6. PubMed ID: 18054264
[TBL] [Abstract][Full Text] [Related]
35. Early assessment of the efficacy of a human papillomavirus type 16 L1 virus-like particle vaccine.
Brown DR; Fife KH; Wheeler CM; Koutsky LA; Lupinacci LM; Railkar R; Suhr G; Barr E; Dicello A; Li W; Smith JF; Tadesse A; Jansen KU
Vaccine; 2004 Jul; 22(21-22):2936-42. PubMed ID: 15246630
[TBL] [Abstract][Full Text] [Related]
36. Human papillomavirus-specific immune therapy: failure and hope.
Nieto K; Gissmann L; Schädlich L
Antivir Ther; 2010; 15(7):951-7. PubMed ID: 21041909
[TBL] [Abstract][Full Text] [Related]
37. Vulvo-vaginal cancers: risks, evaluation, prevention and early detection.
Duong TH; Flowers LC
Obstet Gynecol Clin North Am; 2007 Dec; 34(4):783-802, x. PubMed ID: 18061869
[TBL] [Abstract][Full Text] [Related]
38. Natural history of human papillomavirus infections, cytologic and histologic abnormalities, and cancer.
Wheeler CM
Obstet Gynecol Clin North Am; 2008 Dec; 35(4):519-36; vii. PubMed ID: 19061814
[TBL] [Abstract][Full Text] [Related]
39. [Vaccination against human papillomavirus. Implementation and efficacy against cervical cancer control].
Bégué P; Henrion R; Blanc B; Girard M; Sancho-Garnier H
Bull Acad Natl Med; 2007 Dec; 191(9):1805-16; discussion 1816-7. PubMed ID: 18663976
[TBL] [Abstract][Full Text] [Related]
40. Cervical cancer vaccination indications, efficacy, and side effects.
Bayas JM; Costas L; Muñoz A
Gynecol Oncol; 2008 Sep; 110(3 Suppl 2):S11-4. PubMed ID: 18586311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
